Cambridge Enterprise and Qkine to drive stem cell and regenerative medicine research – Business Weekly
Business Weekly |
Cambridge Enterprise and Qkine to drive stem cell and regenerative medicine research
Business Weekly The newly-licensed methodology, which was developed by one of the company's founders Dr Marko Hyvönen, will be used to manufacture proteins utilised for control of stem cell growth and differentiation. Growth factors are proteins that transmit signals … |
